DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gemigliptin
Gemigliptin
CDR Clinical Review Report for Soliqua
Antidiabetic Drugs in NAFLD: the Accomplishment of Two Goals at Once?
A Prospective Cohort Study on Effects of Gemigliptin On
Pharmacokinetics and Pharmacodynamics of a Fixed-Dose
Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else? Ewa Otto-Buczkowska,1,* and Natalia Jainta2
Essential Medicines List (EML) 2017 Application for the Revision Of
Gemigliptin: an Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus
Beneficial Effect of Anti-Diabetic Drugs for Nonalcoholic Fatty Liver Disease
Clinical Therapeutics/New Technology—Glucose Monitoring and Sensing
2020 Diabetes Guideline Data Supplement
Diabetes Mellitus (1 of 42)
Pharmaceutical Composition for Preventing Or Treating Diabetes, Containing Zinc Salt, Cyclo-Hispro and Antidiabetic Drug As Active Ingredients
Clinical Therapeutics/New Technology— Glucose Monitoring and Sensing 2348‑Pub
Pharmacological Profiles of Gemigliptin (LC15-0444), a Novel
Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids
Novel Treatments for Type 2 Diabetes
Tables S1–S4
A Comparison of Effects of DPP-4 Inhibitor and SGLT2 Inhibitor On
Top View
Dipeptidyl Peptidase 4 Inhibitors for The
9 January 2019 Drugs Used in Diabetes (A10) • Insulins And
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors
Acarbose Add-On Therapy in Patients with Type 2
Modern Management of Diabetes Mellitus Case 1 Case 2 Case 3
Gemigliptin Tartrate Sesquihydrate Tablets 50Mg
New Drugs for Type 2 Diabetes: Second-Line Therapy – Science Report
A Fixed-Dose Combination Tablet of Gemigliptin And
Integrated Physiology/Obesity
A Comprehensive Review and Perspective on Natural Sources As Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
WHO Drug Information Vol
Overview of Type 2 Diabetes Drugs on the Market
Potentiation of Endothelium-Dependent
Online-Only Supplemental Material
Combination Therapy Including Metformin Hydrochloride for the Treatment of Diabetes and Related Comorbidity: a Patent Filed Survey
Lowering Drugs on Body Weight in People with Type 1 Diabetes: a Systematic Review and Network Meta-Analysis Protocol
Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: a Meta-Analysis
An Integrated in Silico and in Vitro Assays of Dipeptidyl Peptidase-4 and Α-Glucosidase Inhibition by Stellasterol from Ganoderma Australe
Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors As Potential Agents to Treat SARS-Cov-2 (2019-Ncov) Infection
New DPP-IV Inhibitor, Gemigliptin “세계를 향한 발돋움”
Original Article Efficacy and Safety of Sitagliptin in Patients with Type 2 Diabetes Mellitus: a Meta-Analysis
Possibility of Pharmacokinetic Drug Interaction Between a DPP-4 Inhibitor and a SGLT2 Inhibitor